Pharmacogenetics of indirect anticoagulants: Value of genotype for improvement of efficacy and safety of therapy

被引:0
|
作者
Sytchev, D. A.
Kropatcheva, E. S.
Ignatiev, I. V.
Bulytova, Yu. M.
Dobrovolsky, A. B.
Panchenko, E. P.
Kukes, V. G.
机构
[1] IM Sechenov Med Acad, Moscow 119881, Russia
[2] AL Myasnikov Inst Clin Cardiol, Moscow 121552, Russia
[3] Inst Clin Pharmacol, Moscow, Russia
关键词
pharmacogenetics; indirect anticoagulants; genetic polymorphism;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The review is devoted to the contemporary state of the problem of pharmacogenetics of indirect anticoagulants. At present there are data about effects of allele variants of CYP2C9, VKORC1, APOE genes on efficacy and safety of therapy with indirect anticoagulants. Detection of these variants is a perspective way to individualization of therapy with indirect anticoagulants.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [21] Comparative efficacy and safety of new oral anticoagulants
    Sulimov, V. A.
    Napalkov, D. A.
    Sokolova, A. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (04) : 433 - 438
  • [22] Efficacy and safety of ledipasvir/sofosbuvir therapy in HCV genotype 1 Korean patients
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 194 - 194
  • [23] Personalized Medicine: Overview of Pharmacogenetics and Safety of Drug Therapy
    Blaih, Salah M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1368 - 1368
  • [24] Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
    Schmeling, Heinrike
    Horneff, Gerd
    Benseler, Susanne M.
    Fritzler, Marvin J.
    NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (11) : 682 - 690
  • [25] Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
    Heinrike Schmeling
    Gerd Horneff
    Susanne M. Benseler
    Marvin J. Fritzler
    Nature Reviews Rheumatology, 2014, 10 : 682 - 690
  • [26] Efficacy and Safety of Direct Oral Anticoagulants in Extremes Weights
    Huang, Julie
    Chin, Jamie
    Hindenburg, Alexander
    Davenport, Lilia
    Willner, Debra
    BLOOD, 2020, 136
  • [27] Efficacy and safety of novel anticoagulants compared with established agents
    Rybak, Iwona
    Ehle, Michael
    Buckley, Leo
    Fanikos, John
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (03) : 175 - 195
  • [28] Safety and efficacy of new anticoagulants in patients with heart failure
    Pisters R.
    Lip G.Y.H.
    Current Heart Failure Reports, 2013, 10 (1) : 18 - 25
  • [29] Direct oral anticoagulants: efficacy and safety in patient subgroups
    Mavrakanas, Thomas A.
    Samer, Caroline
    Fontana, Pierre
    Perrier, Arnaud
    SWISS MEDICAL WEEKLY, 2015, 145
  • [30] Efficacy and safety of triple therapy with novel oral anticoagulants for ischemic heart disease with atrial fibrillation in Japan
    Amano, H.
    Ikeda, T.
    Toda, M.
    Okubo, R.
    Yabe, T.
    Watanabe, I.
    Saito, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 233 - 233